Suppr超能文献

途径研究中的种族/民族、遗传血统与乳腺癌相关淋巴水肿

Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.

作者信息

Kwan Marilyn L, Yao Song, Lee Valerie S, Roh Janise M, Zhu Qianqian, Ergas Isaac J, Liu Qian, Zhang Yali, Kutner Susan E, Quesenberry Charles P, Ambrosone Christine B, Kushi Lawrence H

机构信息

Division of Research, Kaiser Permanente Northern California, Oakland, CA, 94612, USA.

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, 14263, NY, USA.

出版信息

Breast Cancer Res Treat. 2016 Aug;159(1):119-29. doi: 10.1007/s10549-016-3913-x. Epub 2016 Jul 22.

Abstract

Breast cancer-related lymphedema (BCRL) is a serious chronic condition after breast cancer (BC) surgery and treatment. It is unclear if BCRL risk varies by race/ethnicity. In a multiethnic prospective cohort study of 2953 BC patients, we examined the association of self-reported BCRL status with self-reported race/ethnicity and estimated genetic ancestry. Hazard ratios (HR) and 95 % confidence intervals (CI) were calculated by multivariable Cox proportional hazards models, with follow-up starting 6 months post-BC diagnosis. Estimates were further stratified by body mass index (BMI). By 48 months of follow-up, 342 (11.6 %) women reported having BCRL. Younger age at BC diagnosis, higher BMI at baseline, and lower physical activity were associated with greater BCRL risk. African American (AA) women had a 2-fold increased risk of BCRL compared with White women (HR = 2.04; 95 % CI 1.35-3.08). African genetic ancestry was also associated with an increased risk (HR = 2.50; 95 % CI 1.43, 4.36). Both risks were attenuated but remained elevated after adjusting for known risk factors and became more pronounced when restricted to the nonobese women (adjusted HR = 2.31 for AA and HR = 3.70 for African ancestry, both p < 0.05). There was also evidence of increased BCRL risk with Hispanic ethnicity in the nonobese women. Nonobese AA women had a higher risk of BCRL than White women, which cannot be fully explained by known risk factors. This is the first large-scale, prospective study demonstrating differences in BCRL risk according to race/ethnicity as assessed by both self-report and genetic ancestry data, with a potential ancestry-obesity interaction.

摘要

乳腺癌相关淋巴水肿(BCRL)是乳腺癌(BC)手术及治疗后一种严重的慢性疾病。目前尚不清楚BCRL风险是否因种族/民族而异。在一项针对2953例BC患者的多民族前瞻性队列研究中,我们研究了自我报告的BCRL状态与自我报告的种族/民族以及估计的遗传血统之间的关联。通过多变量Cox比例风险模型计算风险比(HR)和95%置信区间(CI),随访从BC诊断后6个月开始。估计值进一步按体重指数(BMI)分层。随访48个月时,342名(11.6%)女性报告患有BCRL。BC诊断时年龄较小、基线BMI较高以及身体活动较少与BCRL风险较高相关。与白人女性相比,非裔美国(AA)女性患BCRL的风险增加了两倍(HR = 2.04;95% CI 1.35 - 3.08)。非洲遗传血统也与风险增加相关(HR = 2.50;95% CI 1.43,4.36)。在调整已知风险因素后,这两种风险均有所减弱,但仍保持升高,并且在仅限于非肥胖女性时更为明显(AA调整后HR = 2.31,非洲血统调整后HR = 3.70,均p < 0.05)。在非肥胖女性中,也有证据表明西班牙裔种族的BCRL风险增加。非肥胖AA女性患BCRL的风险高于白人女性,这无法完全由已知风险因素解释。这是第一项大规模前瞻性研究,通过自我报告和遗传血统数据评估,证明了BCRL风险根据种族/民族存在差异,且存在潜在的血统 - 肥胖相互作用。

相似文献

1
Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.
Breast Cancer Res Treat. 2016 Aug;159(1):119-29. doi: 10.1007/s10549-016-3913-x. Epub 2016 Jul 22.
2
Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
JAMA Oncol. 2022 Aug 1;8(8):1195-1200. doi: 10.1001/jamaoncol.2022.1628.
3
Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort.
PLoS One. 2012;7(3):e30950. doi: 10.1371/journal.pone.0030950. Epub 2012 Mar 27.
7

引用本文的文献

2
Disparities in Breast Cancer-related Lymphedema: A Systematic Review of Inequities and Barriers in Care.
Plast Reconstr Surg Glob Open. 2025 Jul 1;13(7):e6935. doi: 10.1097/GOX.0000000000006935. eCollection 2025 Jul.
3
Metformin Use and Risk of Breast Cancer-Related Lymphedema: A Retrospective Analysis.
J Am Coll Surg. 2025 May 5. doi: 10.1097/XCS.0000000000001434.
9
Lymphatic pain in breast cancer survivors: An overview of the current evidence and recommendations.
Women Child Nurs. 2024 Jun;2(2):33-38. doi: 10.1016/j.wcn.2024.04.001. Epub 2024 Jul 1.
10
Is axillary web syndrome a risk factor for breast cancer-related lymphedema of the upper extremity? A systematic review and meta-analysis.
Breast Cancer Res Treat. 2024 Dec;208(3):471-490. doi: 10.1007/s10549-024-07518-0. Epub 2024 Oct 16.

本文引用的文献

1
An algorithm to identify the development of lymphedema after breast cancer treatment.
J Cancer Surviv. 2015 Jun;9(2):161-71. doi: 10.1007/s11764-014-0393-z. Epub 2014 Sep 4.
2
5
Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort.
Int J Obes (Lond). 2014 Nov;38(11):1416-22. doi: 10.1038/ijo.2014.25. Epub 2014 Feb 13.
6
Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients.
Breast Cancer Res Treat. 2014 Feb;144(1):71-7. doi: 10.1007/s10549-014-2856-3. Epub 2014 Feb 6.
7
Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer.
Breast Cancer Res Treat. 2013 Nov;142(1):59-67. doi: 10.1007/s10549-013-2715-7.
8
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.
Lancet Oncol. 2013 May;14(6):500-15. doi: 10.1016/S1470-2045(13)70076-7. Epub 2013 Mar 27.
9
Risk factors associated with breast cancer-related lymphedema in the WHEL Study.
J Cancer Surviv. 2013 Mar;7(1):115-23. doi: 10.1007/s11764-012-0251-9. Epub 2012 Dec 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验